Definitive Contract HHSD200201796195C
- Not listed
- This is a $300,000.00 firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Rutgers, The State University of New Jersey, doing business as RBHS-New Jersey Medical School, for multidrug resistance research. The contract has a completion date of September 29, 2018 and was not set aside for any specific business category. Rutgers is a non-profit organization, 1862 land grant college, and educational institution that has previously provided medical...
- This is a $191,904 cost-reimbursement contract awarded by the Centers for Disease Control and Prevention (CDC) to Rutgers, The State University of New Jersey. The contract, titled "UNLOCKING ECOLOGY OF ARB," has a period of performance from September 16, 2016 to March 31, 2018. Rutgers, as a major public research institution, has extensive experience conducting research and development for federal agencies such as the Department of Defense, NASA, and the Department of Health and...
- This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The $300,216 Firm Fixed Price contract was awarded to Rutgers, The State University to support "Computational Thinking to Support Clinicians and Biomedical Scientists". This work was funded through the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation....
- This contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Rutgers, The State University of New Jersey to establish the Tuberculosis Trials Consortium. The $4,376,313.00 definitive cost-type contract has a period of performance ending on September 17, 2019. It is not a set-aside contract. Rutgers is a major public research university that conducts a wide range of federally-funded research and development across disciplines. Through this...
- This federal contract award is for the creation of induced pluripotent stem cells, awarded by the National Institute on Drug Abuse, a civilian agency, to Rutgers, The State University. The $68,042.40 firm fixed-price purchase order was awarded on September 16, 2020, with a completion date of September 20, 2021. The contract is not set aside for any particular business type. Rutgers is a major public research university and a prominent land-grant institution, with extensive capabilities in...
- This contract award is for tuition to support training of two employees from the National Institutes of Health National Institute of Allergy and Infectious Diseases. The $7,355.50 firm fixed-price purchase order was awarded to Rutgers, The State University of New Jersey, operating through its Cancer Institute of New Jersey. Rutgers is a non-profit, land grant educational institution that has received multiple federal grants and contracts for cancer research and related services. While this...
- This is a $10,830.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Rutgers, The State University of New Jersey, doing business as the Cancer Institute of New Jersey. The contract provides tuition for an NIH fellow/graduate student to be performed in New Brunswick, New Jersey by the December 22, 2017 completion date. This award is not associated with a larger contract vehicle, and there is no set-aside...
- This is a $749,628 grant for research awarded by the Shared Services Center, a civilian government agency, to Rutgers The State University of New Jersey on May 17, 2024. The contract, which has an ultimate completion date of April 30, 2027, is for a project titled "PIONEER PEPTIDES: ANCIENT BIOMOLECULES THAT POWERED THE FIRST METABOLIC NETWORKS." The contract is not set aside for any specific business type. Rutgers, a non-profit educational institution, will be performing the work in...
- This federal contract award, valued at $964,769.00, was issued by the Food and Drug Administration (FDA) to Rutgers, The State University. The award is a definitive contract with a firm fixed price and supports research and development for "ROLE OF EXCIPIENTS AND EXCIPIENT SUBSTITUTION IN TOPICAL SEMI-SOLID FORMULATIONS AND THEIR EFFECT ON PRODUCT PERFORMANCE AND QUALITY." The contract has a period of performance ending on December 29, 2025, with an ultimate completion date of...
- This is a $10,525.00 firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Rutgers, The State University of New Jersey, for SNRNA sequencing services to support the VA New Jersey Healthcare System. The contract has a completion date of September 30, 2024. Rutgers The State University of New Jersey, through its RBHS-School of Nursing division, has extensive experience providing services to federal agencies through both...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Rutgers, The State University of New Jersey, doing business as RBHS-New Jersey Medical School, a non-profit educational institution. The contract, with a firm fixed price of $150,000.00, is for rapid identification of Candida auris, a fungal pathogen of public health concern. The contract does not have a set-aside designation and was awarded on September 21, 2017, with a completion date of September 28, 2018. Rutgers, The State University, through its Research Financial Services Division, has a history of providing various research and development services to federal agencies such as the Department of Health and Human Services, Department of Defense, and National Science Foundation. This includes past contracts and grants in areas like addiction genetics, quantum computing, and infectious disease research.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Rapid identification and analysis of virulence and persistence of the emerging pathogen Candida auris | CDCBAAFY2017-OADS-01-96195C | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Award Notice 1/1 | 10/7/17, 12:15 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 6/30/23 | |
| 1 | Supplemental Agreement for work within scope | $0 | 9/4/18 | |
| Not listed | Not listed | $150.0k | 9/22/17 |